Experts worry insulin getting too expensive for many in U.S. and worldwide

Eric Palmer Healthcare professionals are concerned that hormone insulin meds, often the key diabetes treatment, are getting too costly for many patients, even in the U.S. In developing ...

Video: Experts predict the future of Big Data at #JPM16

Alok Saboo FierceBiotech News

Next-gen antibody experts at AnaptysBio file $86M IPO

John Carroll Up to now, San Diego-based AnaptysBio has raised close to $ 49 million in cash directly from collaborators looking to the antibody shop to use their technology to create ...

Geriatrics experts call for halt to Low-T consumer ads

Tracy Staton A couple of geriatrics experts have joined the chorus of recommendations against testosterone therapy. But they're going a step further. They say drugmakers' enthusiastic ...

Some psych experts want FDA to yank black-box warning on antidepressants

Emily Wasserman In the 10 years since the FDA found that antidepressants carried an increased risk of suicidal thoughts and behaviors in teens and slapped a black box warning on the ...

UPDATED: FDA experts spurn AstraZeneca’s pitch for ovarian cancer drug olaparib

John Carroll AstraZeneca's top investigators took their best case for an accelerated approval of the failed cancer drug olaparib to the FDA's panel of outside experts on Wednesday, ...

Experts foresee premium pricing for overdose-fighting injector Evzio

Tracy Staton Amid fierce debate over hepatitis C drug costs, another example of potentially questionable pricing looms, The New York Times contends. The new anti-overdose injector, ...

ADHD experts worry that pharma ads drive too many kids to meds

Tracy Staton Is the huge rise in attention-deficit hyperactivity disorder diagnoses a pharma coup or public-health boon? FiercePharma News

FDA experts vote against expansion of Amarin’s Vascepa

Eric Palmer An FDA advisory panel is against extending the use of Amarin's fish-oil drug Vascepa with a cholesterol-lowering statin to reduce the risk of coronary disease; they ...

One in Three Hospitalized Patients is Malnourished; Experts Call for Better Diagnosis and Treatment

barbara.lempert Underperformed Nutrition Assessment Associated with Poorer Outcomes and Higher Cost SILVER SPRING, Md., Sept. 24, 2013 /PRNewswire/ — Multiple studies find that ...

FDA experts endorse new COPD blockbuster from GlaxoSmithKline, Theravance

John Carroll GlaxoSmithKline and Theravance have nailed down a solid majority of FDA panel votes in favor of marketing their new COPD therapy Anoro Ellipta. The outside experts voted ...

Fate Therapeutics, founded by stem cell experts, targets $69M IPO

Ryan McBride San Diego-based Fate Therapeutics has become the latest drug developer to toss its hat in the IPO ring, aiming to score as much as $ 69 million, the company said in an ...
Page 1 of 212
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS